IM Cannabis Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMCC research report →
Companywww.imcannabis.com
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands.
- CEO
- Oren Shuster
- IPO
- 2020
- Employees
- 95
- HQ
- Tel Aviv, IL
Price Chart
Valuation
- Market Cap
- $749.15K
- P/E
- -14.53
- P/S
- 0.45
- P/B
- 4.72
- EV/EBITDA
- -80.47
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 24.79%
- Op Margin
- -51.59%
- Net Margin
- -2.97%
- ROE
- -24.38%
- ROIC
- -95.00%
Growth & Income
- Revenue
- $54.73M · 1.30%
- Net Income
- $-11,319,000 · -6.93%
- EPS
- $-2.67 · 40.80%
- Op Income
- $-11,587,000
- FCF YoY
- 481.43%
Performance & Tape
- 52W High
- $7.12
- 52W Low
- $0.22
- 50D MA
- $0.41
- 200D MA
- $1.33
- Beta
- 2.02
- Avg Volume
- 537.79K
Get TickerSpark's AI analysis on IMCC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IMCC Coverage
We haven't published any research on IMCC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IMCC Report →